Skip to Content
Søk Menu
Välkommen till lungcancer

Få de senaste artiklarna och MEDtalks om lungcancer.

Senaste nytt om lungcancer

New Data Support Osimertinib as a Backbone Treatment for EGFRm Advanced NSCLC

  • / Jan Andreasen
Michael Stenger

WCLC 2025: Lung Cancer Screening and Early Results from the Danish PLUS Trial

/ Michael Stenger
LungcancerWCLC25 Play the Video

Amivantamab + Lazertinib in EGFR-Mutated Advanced NSCLC: PALOMA-2 Update

/ Jan Andreasen
LungcancerNSCLCWCLC25

Första linjens NSCLC utan cancerdrivande mutationer: praktik, brister och kostnader

/ Ronny Öhman / Jan Andreasen
LungcancerNSCLC

Artiklar

New Treatment Possibilities Improve Future Outcomes of Lung Cancer

/ BestPractice Nordic
ESMO24Lungcancer

No Major Breakthroughs in Lung Cancer Compared to ESMO 2023

/ BestPractice Nordic
ESMO24Lungcancer

CheckMate 227: 6-year data on the treatment of locally advanced NSCLC with Opdivo and Yervoy  

/ BestPractice Nordic
LungcancerNSCLCWCLC23

Adjuvant treatment with 3rd generation EGFR-TKI can increase progression-free survival 

/ BestPractice Nordic
LungcancerNSCLCWCLC23

WCLC 2023 – NSCLC: New Data on Perioperative Immunotherapy Treatment 

/ BestPractice Nordic
ImmunterapiLungcancerNSCLCWCLC23

CheckMate 9LA – Investigating the role of immunotherapy combinations in patients with non-small cell lung cancer

/ Martin Reck
Lungcancer

WCLC I Kongresside

6.-9. september 2025

MEDtalks

Maria Silvoniemi

Clinical Dilemmas in the Management of NSCLC Without Driver Mutations

/ Maria Silvoniemi
LungcancerNSCLC Play the Video
Luis Paz-Ares

ASCO 2025: Lurbinectedin–Atezolizumab Improves Survival in SCLC

/ Luis Paz-Ares
ASCO25Lungcancer Play the Video
Miriam Grønberg

Treatment Timing Impacts Survival in Limited Stage Small Cell Lung Cancer

/ Miriam Grønberg
Lungcancer Play the Video
Karin Lindberg

Kliniska fördelar med stereotaktisk strålbehandling vid oligometastatisk non-small cell lungcancer, NSCLC

/ Karin Lindberg
LungcancerOnkologisk Forum 2024 Play the Video

Outstanding Results for the Treatment of Lung Cancer

/ Tony Mok
Lungcancer Play the Video
Edyta Maria Urbanska

New Tendencies in Development of ALK-TKIs for Treatment of ALK-Rearranged NSCLC

/ Edyta Maria Urbanska
Lungcancer Play the Video
Load more
Oluf Dimitri Røe

ASCO24: Very Exciting Steps for Early Diagnosis and Lung Cancer

/ Oluf Dimitri Røe
ASCO24Lungcancer Play the Video
Edyta Maria Urbanska

Younger Patients with Lung Cancer Treated with ALK Tyrosine Kinase Inhibitors Seem to be Prone to Return to Work

/ Edyta Maria Urbanska
Lungcancer Play the Video
Vivi Quoc Nguyen

Carboplatin is a Viable Option in Treating Patients with Completely Resected Non-Small Cell Lung Cancer

/ Vivi Quoc Nguyen
Lungcancer Play the Video
Odd Terje Brustugun

Onkologisk Forum: Highlights in Lung Cancer Treatment

/ Odd Terje Brustugun
Lungcancer Play the Video
Nathan Harrison

Interventions Designed to Reduce Lung Cancer Stigma

/ Nathan Harrison
LungcancerWCLC23 Play the Video
Jonathan Spicer

Perioperative Pembrolizumab Shows Significant OS in ResectableNon-Small-Cell Lung Cancer

/ Jonathan Spicer
ESMO23Lungcancer Play the Video
Masahiro Tsuboi

Efficacy of Osimertinib in resected EGFR-Mutated stage IB-IIIA NSCLC

/ Masahiro Tsuboi
Lungcancer Play the Video

5-Years Data: High-Dose Thoracic Radiotherapy Increases OS Significantly for Patients with Limited Stage of Small-Cell Lung Cancer

/ Bjørn Henning Grønberg
ASCO23Lungcancer Play the Video
Load more
Back to top